Diagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumors
- 333 Downloads
In order to predict whether tumor markers assist in the histopathologic diagnosis of germ cell tumors (GCTs), we analyzed the correlation of beta human chorionic gonadotropin (βhCG) and alpha-fetoprotein (AFP) in serum and cerebrospinal fluid (CSF) samples at baseline and subsequent follow-up examinations.
A retrospective study of patients diagnosed with intracranial GCTs between July 1985 and February 2011 at our institution was conducted to review clinical, surgical, radiological, laboratory, and histopathologic data.
Of the 67 patients eligible for the study, 42 had germinomas and 25 non-germinomatous GCTs. At baseline, serum and CSF AFP agreed in 97.9 % of patients (Cohen’s Kappa 0.93). Baseline βhCG samples agreed in only 72.5 % of patients (Cohen’s Kappa 0.46). In most cases, values were higher in serum for AFP and in CSF for βhCG. ROC curves estimated from logistic regression model indicated that CSF and serum samples had almost equal diagnostic utility, and the DeLong test showed that the difference in area under curves was not statistically significant. During follow-up (185 paired CSF and serum values from 43 patients), 90.3 % of AFP values correlated between CSF and serum (Cohen’s Kappa 0.22, showing fair agreement). For βhCG, 96.2 % of values agreed in serum and CSF (Cohen’s Kappa 0.61).
In some patients, intracranial GCTs can be diagnosed based solely upon positive serum AFP values. In addition, marker values from serum only may be sufficient to predict tumor relapse at interval follow-up examinations.
KeywordsGerm cell tumors Tumor markers Beta human chorionic gonadotropin Alpha-fetoprotein Correlation of markers Diagnostic utility
This work was supported in part by Cancer Center Support Grant CA21765 from the National Cancer Institute, The Noyes Brain Tumor Foundation, Musicians Against Childhood Cancer, and the American Lebanese Syrian Associated Charities. The authors would like to acknowledge Vani Shanker for the scientific editing of the manuscript and Julie Groff for support of the artwork.
- 2.Allen JC, Donahue B, Mathew N et al (2010) Can serum and/or lumbar CSF BHCG be used to diagnose A CNS germinoma. Neuro-Oncology 12:i29Google Scholar
- 3.Bernstein L, Smith MA, Liu L et al (1994) Germ cell, trophoblastic and other gonadal neoplasm ICCC X. SEER Pediatric Monograph 125–137Google Scholar
- 8.Fujimaki T, Mishima K, Asai A, Tabuchi K, Kobayashi M, Suzuki I, Kirino T (2000) Levels of beta-human chorionic gonadotropin in cerebrospinal fluid of patients with malignant germ cell tumor can be used to detect early recurrence and monitor the response to treatment. Jpn J Clin Oncol 30:291–294PubMedCrossRefGoogle Scholar
- 12.Kawaguchi T, Kumabe T, Kanamori M et al (2011) Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with a better response among highly malignant intracranial non-germinomatous germ cell tumors. J Neurooncol 104:779–787PubMedCrossRefGoogle Scholar